ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition

April 18, 1986

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982

Guidelines Working Group Agrees On 4750,00 As Base; Steckel Says AACI May Object To “Freeze” On Core

November 21, 1980

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990